1 Reason Dendreon Continues to March Higher

Dendreon (NASDAQOTH: DNDNQ  ) is posting another day of impressive gains, and with today's high-single-digit move, the stock has gained about 75% from its early November lows. That's not to say things are looking great for the company  -- all it takes is a glance at the stock price from early 2011 to remember just how far the maker of prostate cancer treatment Provenge has fallen. But as Brenton Flynn outlines in the video below, there's likely one simple explanation for the outsized gains we've seen over the past 90 days.

Interested in the full story behind Dendreon? Be sure to check out our brand new premium research report on this roller coaster stock. Inside, our Denderon expert David Williamson details every key issue facing the company and outlines just how Dendreon intends to regain its former glory. The report also comes with a full year of analyst updates, so claim your copy of this exclusive report today by clicking here now.

Read/Post Comments (1) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On February 06, 2013, at 9:46 PM, lebronz wrote:

    All it takes is a glance at the short interest "trend" since Aug 2011 to today to see why the stock price declined steadily the last 16 months.

    Short interest went from 14 million (Aug 2011) to 47.2 million today while institutional holdings remained steady near 60%.

    Yes, there was a little pop in Feb 2011 due to some planned covering, but then the short interest continued its steady climb to 47.1 million shares in Nov 2011.

    Now with Deerfield and Blackrock Inc recent purchase (nearly 9 million a piece), you can expect tute holdings to be much higher than 60% when its reported on May 15

    Massive short selling nearly 2million shares per month to distort the true value of dndn during the last 16 months is legal and effective at forcing retail to give up & sell. Large investors want in dndn bad because dndn doesn't need & wont give them another secondary offering.

    Dndn is on the precipice of profitability so keep telling everyone to BUY!


Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2239787, ~/Articles/ArticleHandler.aspx, 10/1/2016 11:32:30 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 14 hours ago Sponsored by:
DOW 18,308.15 164.70 0.91%
S&P 500 2,168.27 17.14 0.80%
NASD 5,312.00 42.85 0.81%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
DNDNQ $0.00 Down +0.00 +0.00%
Dendreon Corp CAPS Rating: *
JNJ $118.13 Up +0.86 +0.73%
Johnson and Johnso… CAPS Rating: *****
MDVN $0.00 Down +0.00 +0.00%
Medivation CAPS Rating: ****